Loophole in Finnish Law Fosters Counterfeit Drug Trade
The International edition of Helsingin Santomat has highlighted the recent surge in transhipments of counterfeit medications through Finland to the world market. It quotes Anssi Kartila of the Finnish Board of Customs as attributing this upsurge to the absence of effective laws: "Transit for medicines is unrestricted. Cases are investigated only if the holder of a medicine's brand name or patent files a criminal complaint alleging fraud. In other cases the medicines will be allowed to pass through." The Customs Board believes that the counterfeit drugs that enter Finland are generally not intended for the Finnish market. Instead, they usually originate in India or China and pass through Finland in transit to Central Europe or Russia.
Post A Comment / Question